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OBJECTIVES: This study evaluated plantar thermography sensitivity and specificity in diagnosing diabetic
polyneuropathy using cardiac tests (heart rate variability) as a reference standard because autonomic small fibers
are affected first by this disease.
METHODS: Seventy-nine individuals between the ages of 19 and 79 years old (28 males) were evaluated and divided
into three groups: control (n = 37), pre-diabetics (n = 13) and type 2 diabetics (n = 29). The plantar images were
recorded at baseline and then minutes after a provocative maneuver (Cold Stress Test) using an infrared camera that
is appropriate for clinical use. Two thermographic variables were studied: the thermal recovery index and the
interdigital anisothermal technique. Heart rate variability was measured in a seven-test battery that included three
spectral indexes (in the frequency domain) and four Ewing tests (the Valsalva maneuver, the orthostatic test, a deep
breathing test, and the orthostatic hypotension test). Other classically recommended tests were applied, including
electromyography (EMG), Michigan inventory, and a clinical interview that included a neurological physical
examination.
RESULTS: Among the diabetic patients, the interdigital anisothermal technique alone performed better than the
thermal recovery index alone, with a better sensitivity (81.3%) and specificity (46.2%). For the pre-diabetic patients,
the three tests performed equally well. None of the control subjects displayed abnormal interdigital anisothermal
readouts or thermal recovery indices, which precluded the sensitivity estimation in this sample of subjects. However,
the specificity (70.6%) was higher in this group.
CONCLUSION: In this study, plantar thermography, which predominately considers the small and autonomic fibers
that are commonly associated with a sub-clinical condition, proved useful in diagnosing diabetic neuropathy early.
The interdigital anisothermal test, when used alone, performed best.
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INTRODUCTION
Peripheral neuropathy is a common complication in
diabetes mellitus (DM) that leads to serious functional
disability; however, its evaluation has not been standar-
dized (1-7). Electromyography with nerve conduction
assessment is the neurophysiological test that confirms the
distal symmetric polyneuropathy that is typical of diabetes,
and it is the standard protocol in most centers that specialize
in neuropathy (6-9). However, this test does not evaluate
small fibers, is minimally invasive, requires expertise, and
is time consuming (5,6). The clinical aspects, including
validated inventories, are valued in specialized diabetes
centers; nevertheless, the screening for subclinical cases has
low sensitivity, as demonstrated by the absence of symp-
toms or signs of distal symmetrical polyneuropathy.
Small fiber neuropathy may occur at any stage of
diabetes, including during pre-diabetes. It is often painful,
even in the absence of abnormalities, which are measured
using conventional standard neurophysiological tests. The
discrepancy between clinical presentation and test results
could delay the correct diagnosis and appropriate treatment
(8,10-12). Many diagnostic methods can assess small fibers;
however, no single test can make this diagnosis. A battery of
sensitive, reproducible and specific tests covering the
somatic and autonomic systems is recommended (5,11,12).
These tests include cardiovascular monitoring, sudomotor
testing, pupillary responses, quantitative sensory tests, laser
evoked potentials and thermography (12).
Using such techniques has proven useful not only for
diagnosis but also for guiding adequate therapy and
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optimizing the follow-up. Infrared computerized thermo-
graphy is a method of visualization, documentation and
measurement of the infrared rays along the human body.
According to Stefan-Boltzmann, this emission is propor-
tional to the temperature of the skin and is directly related
to blood flow in the cutaneous vessels (13,14,15). This
method offers some advantages over others because it is
completely non-contact, is painless and does not generate
inputs beyond the equipment itself.
In diabetes, vascular activity in the extremities, especially
in the feet, may be indicative of autonomic neuropathy.
Because vasomotor tone is regulated by fibers from the
neurovegetative sympathetic system, its dysfunction could
be associated with varying temperature patterns (16-19).
Peripheral neurovegetative sympathetic nerve degeneration
in advanced neuropathy damages the neurogenic control
mechanisms that regulate capillary and arteriovenous (AV)
shunt flow, which leads to an increase in the AV shunt in
the feet of patients with diabetic neuropathy (20-23). These
shunts are maintained in the constricted state by neurove-
getative sympathetic tone. Losing this tone because of
sympathetic neuropathy results in the shunt opening and
the deviation of blood flow from the skin (20-23).
Because of the great vulnerability that small fibers have to
metabolic changes associated with hyperglycemia, injuries
to these fibers may present earlier and with less marked
changes than sensory-motor neuropathies (24,25). Although
diabetic neuropathies are classified as diabetic microangio-
pathic complications, it is now known that their pathophy-
siological mechanism is multifactorial, and there is
sufficient evidence that small-fiber polyneuropathy and
even cardiac autonomic neuropathy may precede diabetes
(i.e., during the pre-diabetic condition) (26-29).
Cardiovascular reflex tests are standard for clinical
autonomic evaluation because of their good sensitivity,
specificity, and reproducibility; these tests are also non-
invasive and well standardized. However, these tests
require a well-trained evaluator and considerable evalua-
tion time. Cardiovascular reflex tests can identify cardiac
autonomic neuropathy even at the subclinical stage (29-36).
This type of neuropathy can be subdivided into subclinical
(predominantly functional and reversible) and clinical
(structural neuronal changes are present). The subclinical
subtype can only be diagnosed by tests and may occur as
early as the time of the initial diabetes diagnosis. The clinical
subtype is symptomatic and occurs during more advanced
disease stages (35).
The autonomic nerves are affected in various clinical
diabetic neuropathy subtypes. In the most common type
(typical polyneuropathy: symmetric, distal, and predomi-
nantly sensory), there is a strong correlation between the
progressive damage of the somatic and autonomic fibers.
Indeed, 50% of diabetic patients with polyneuropathy have
asymptomatic cardiac autonomic neuropathy, while 100% of
patients with symptomatic cardiac autonomic neuropathy
have polyneuropathy (3,37). The prevalence of cardiac
autonomic neuropathy progressively increases in direct
proportion to age, diabetes duration, and poor glucose
control.
The aim of this study was to evaluate plantar thermo-
graphy sensibility and specificity in diabetic patients with
polyneuropathy at the diagnosis using cardiac tests (heart
rate variability) as a reference standard because the auto-
nomic small fibers are first affected, and there is a close
relationship with cardiac and somatic autonomic nerve fibers
in diabetes (18,23).
MATERIALS AND METHODS
This study was performed from March 2010 to August
2011. The principles of the Declaration of Helsinki (38) were
applied, and all of the patients provided informed written
consent. The study was approved by the Ethics Committee
of the Hospital de Clı´nicas de Porto Alegre (HCPA), RS,
Brazil, decision No. 09-446, January 2010.
Subjects
Seventy-nine individuals aged between 19 and 79 years
(28 males) were evaluated and divided into three groups:
controls (n = 37), pre-diabetics (n = 13), and type 2 diabetics
(n = 29). The patients with pre-diabetes and diabetes were
referred to the study from the Endocrinology and Pre-
diabetes Out-clinic Unit of the Hospital de Clı´nicas de Porto
Alegre (Porto Alegre, Brazil). Diabetes and pre-diabetes
were defined according to the American Diabetes
Association (ADA) criteria (9). The control group consisted
of volunteers that did not fit the criteria for type 2 diabetes
or pre-diabetes. Smokers and subjects with other conditions
that could potentially cause neuropathies, such as hypothyr-
oidism and alcoholism, or a condition in which the thermal
plantar images could mimic neuropathy, such as lumbosa-
cral radiculopathy, were excluded. Ischemic heart disease or
stroke patients were also excluded because of the heart rate
variability tests were used.
Data collection and instrumentation
The data collection was conducted at a controlled
laboratory temperature of 23¡0.5 C˚ and a relative humidity
of 50¡5%. All of the tests occurred on the same day and
lasted 1.5 hours per participant.
Clinical evaluation
Clinical data, including age, gender, body mass index, and
arterial systolic and diastolic pressure, were collected on the
evaluation day. The clinical diagnosis of distal symmetric
polyneuropathy was assessed using the Michigan inventory
(39), a neuropathy score that consists of an inspection of foot
deformities or ulcers and a brief neurological examination. We
used the Achilles reflex test, a vibration sensitivity test on the
hallux dorsum with a 128 Hz tuning-fork and a test for tactile
sensibility using 10 g of nylon monofilament (SoryH, Bauru-
SP-Brazil) on the plantar aspect of the hallux. The Michigan
inventory was considered to be positive for neuropathy when
four or more points (of a possible ten) were scored.
Heart rate variability
Both the ADA and the American Academy of Neurology
(AAN) (40,41) recommend the following protocol: three
Ewing tests (the deep breathing test, Valsalva maneuver,
and orthostatic test) at the time of a type 2 diabetes
diagnosis and five years after a type 1 diabetes diagnosis
and repeated annually thereafter. These three tests per-
formed together have good reproducibility and specificity
above 91%; the deep breathing and orthostatic tests have
93% sensitivity, and the Valsalva maneuver has 98%
sensitivity. In addition, a spectral analysis was performed
for heart rate variability, which is a result of sympathetic
and parasympathetic balance at the sinus node. The method
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consists of seven parameters that are evaluated together,
including a three-band spectral analysis of heart rate
variability and four Ewing tests (the Valsalva maneuver,
orthostatic test, deep breathing test and orthostatic hypoten-
sion test); this method has 98% sensitivity and 100%
specificity (35).
To evaluate the presence of cardiac autonomic neuropathy,
heart rate variability tests were performed. These tests
comprised three spectral indices (in the frequency domain)
and four Ewing tests (35), including the Valsalva maneuver,
orthostatic test, deep breathing test, and orthostatic hypoten-
sion test. The electrocardiogram was recorded (particularly
the QRS complex) using electrocardiography equipment
(NeurosoftH, Ivanovo, Russia) and software that was created
for heart rate variability analysis (Poly-SpectrumH). A ques-
tionnaire concerning autonomic dysfunction symptoms was
given following the protocol described by Rolim et al. (35).
The presence of incipient cardiac autonomic neuropathy
was defined as having two abnormal tests (98% specificity),
and established neuropathy was diagnosed when three tests
were abnormal (100% specificity) (35). In this study, we
considered patients to be either positive or negative for
cardiac autonomic neuropathy.
Plantar thermography
The plantar infrared images were recorded using three
thermal infrared cameras (the PV320T Electrophysics, IRI
4010 IRYSIS, and T400 Flir) with thermal sensitivities of 0.08
and 0.01 C˚, a full-scale spectral range between 7-12 and 8-14
m and a maximum error of 2%. The protocol for infrared
images followed the recommendations of the American
Academy of Thermology (42). Notably, caffeinated drinks or
other vasoactive substances were suspended for at least
eight hours prior to testing, and all prescribed medications
were suspended 12 hours prior to testing.
The participants were acclimated for 15 minutes in the
examination room by lying on a stretcher with bare legs and
feet and no surface contact. The plantar infrared image was
recorded at baseline followed by the provocative maneuvers
using the cold stress test. This test consists of immersing the
feet, which are protected with thin plastic, for 60 seconds in
water at 15 C˚. After 10 minutes, a new plantar infrared image
was recorded to evaluate the thermal recovery index. To
calculate the recovery index, the average temperatures of 10
regions of interest with similar dimensions were used: the
hallux, 1st, 3rd, and 5th metatarsal heads and heel on both









TRI: thermal recovery Index; TaB: the average basal
temperature of the 10 ROI ( C˚); Ta10’CST: the average
temperature 10 minutes after the cold stress test of the 10
ROI ( C˚); L: left foot; R: right foot; ha: hallux; 1 mh: 1st
metatarsal head; 3 mh: 3rd metatarsal head; 5 mh: 5th
metatarsal head; he: heel.
The interdigital anisothermal was assessed and was
considered to be positive when thermal gradients (DT)
$0.4 C˚ existed between any of the toes 10 minutes after the
cold stress test (41-49). Figure 1 shows two examples of the
interdigital anisothermal test.
In this study, which is based on specific literature, an
interdigital anisothermal result or a thermal recovery index
of ,90% or .100% after the cold stress test were considered
(alone or in combination) to be positive for early neuropathy
(small fibers and neurovegetative sympathetic fibers with
vasomotor functions) (42-50).
Electromyography
The neuropathy screening protocol included the func-
tional assessment of motor and sensory nerves of the four
segments, as well as a myography using a needle electrode in
suspected cases of axonal injury or root involvement (3,5-8).
To record and analyze the data, a two channel electromyo-
gram (NeurosoftH, Ivanovo, Russia) and dedicated software
(NeuroMepH) were used. This method classifies the neuro-
pathy into its various manifestations (i.e., mononeuropathies,
multiple mononeuropathy and polyneuropathy). In this
study, EMG was considered to be positive when it demon-
strated distal symmetric polyneuropathy and was typical of
Figure 1 - (A) Plantar thermographic image in a diabetic patient,
showing Interdigital Anisothermal (the white arrow shows the
different colors in toes meaning DT $ 0.4˚C). (B) Plantar
thermographic image in a control subject, with regular thermal
distribution, without Interdigital Anisothermal (color gradient of
toes considered normal, DT , 0.4˚C).
CLINICS 2012;67(12):1419-1425 Thermography in diabetic neuropathy
Balbinot LF et al.
1421
diabetic neuropathy (5,7,51,52). The evaluator was blinded to
the other test results.
Statistical analysis
The categorical variables were described by absolute and
relative frequencies, and the continuous variables were
described by the mean and standard deviation (SD) or the
median and interquartile range. The cutoff point for infrared
thermography, which was represented by the thermal
recovery index in this study using heart rate variability as
a reference standard, was obtained by creating a receiver
operating characteristic (ROC) curve. The area under the
curve was used to estimate the accuracy of the method. The
Kappa coefficient was assessed to analyze the agreement
between the thermographic methods versus heart rate
variability. The association between the categorical variables
was assessed using the chi-squared test or Fishers exact test.
The means were compared using Student’s t-test or a one-
way analysis of variance (ANOVA) with Tukey’s post-hoc
test. In asymmetric cases, a Mann-Whitney U-test was
applied. A significance level of 5% was adopted, and all of
the statistical analyses were performed using SPSS
(Statistical Package for the Social Sciences) version 18.0.
RESULTS
The analyses were separated by group because the groups
were not homogeneous, with the exception of gender. The
control subjects were younger (p= 0.001) and had a lower
body mass index than the pre-diabetic subjects (p,0.001).
The controls also had lower blood pressure values than the
diabetic and pre-diabetic subjects (systolic, p,0.001, diasto-
lic, p= 0.012), as shown in Table 1.
For the three glycemic statuses, the pre-DM group
presented with the highest thermal recovery index and
had abnormal interdigital anisothermal results. The DM
group presented with the highest number of abnormal
results from the neuropathy diagnosis tests (heart rate
variability, Michigan inventory, and EMG), as reported in
Table 2. Although we observed a greater number of positive
results for neuropathy diagnosis, only 6.9% (n = 2) of the
patients from the DM group presented with a positive
Michigan inventory test, thus identifying clinical neuro-
pathy by the loss of protective foot sensation.
Cardiac autonomic neuropathy (diagnosed using the
heart rate variability method) was the reference used to
estimate the sensitivity and specificity of the plantar
infrared thermography. The interdigital anisothermal test
and the thermal recovery index, alone or in combination,
were used to identify the subjects with cardiac autonomic
neuropathy in the three groups (Table 3). In the diabetic
subjects, the interdigital anisothermal test alone performed
better than the thermal recovery index, and both had better
sensitivity (81.5%) and specificity (46.2%). For the pre-
diabetic patients, all three tests performed equally well
(sensitivity 80.0%, specificity 25.0%). None of the control
subjects had abnormal results for the interdigital anisother-
mal test or the thermal recovery index, which would have
precluded the sensitivity estimation in this sample of
subjects. However, the specificity was higher in the control
subjects (70.6%).
Because the interdigital anisothermal test performed best,
the clinical data regarding the results of this test are
depicted in Table 4. In the pre-diabetic patients, the clinical
data were significantly different between the subjects who
presented or did not present with interdigital anisothermal
results. The subjects in the pre-DM group who presented
Table 1 - Patient characteristics.
Variables* DM (n=29) Pre-DM (n=13) Control (n = 37) p-value
Age (years) 55.9¡9.4b 56.8¡12.6b 45.1¡14.9a 0.001
Gender (Female/Male) 20/9 10/3 21/16 0.350
Time of diagnosis (years) 5 (2-9) 1 (1-2) - ,0.001
Body mass index (kg/m2) 27.1¡4.0ab 30.0¡2.8)b 25.3(3.8)a ,0.001
Systolic BP (mmHg) 131.7¡8.0b 130.5¡6.2b 121.7(9.0)a ,0.001
Diastolic BP (mmHg) 85.9¡7.9b 83.5¡6.3ab 79.7(8.8)a 0.012
BP: Blood Pressure. * Mean¡standard deviation or median (25th percentile to 75th percentile). a,b Same letters do not differ by Tukey’s post hoc test at the
5% significance level.
Table 3 - Comparison of the methods.
Comparisons % abnormal Sensibility (%) Specificity (%)
DM Group (n=29)
HRV6TRI 55.2675.9 75.0 23.1
HRV6IDA 55.2669.0 81.3 46.2
HRV6both (TRI+IDA) 55.2651.7 56.3 53.8
Pre-DM Group (n=13)
HRV6TRI 38.5676.9 80.0 25.0
HRV6IDA 38.5676.9 80.0 25.0
HRV6both (TRI+IDA) 38.5676.9 80.0 25.0
Control Group (n =37)
HRV6TRI 8.1637.8 - 58.8
HRV6IDA 8.1635.1 - 61.8
HRV6both (TRI+IDA) 8.1627.0 - 70.6
HRV: heart rate variability; TRI: thermal recovery index, IDA: interdigital
anisothermal.
Table 2 - Absolute and relative frequencies of neuropathy
test results according to glycemic status.
Test DM (n=29) Pre-DM (n=13) Control (n = 37)
Abnormal Normal Abnormal Normal Abnormal Normal
TRI (%) 22 (75.9) 7 (24.1) 10 (76.9) 3 (23.1) 14 (37.8) 23 (62.2)
IDA (%) 20 (69.0) 9 (31.0) 10 (76.9) 3 (23.1) 13 (35.1) 24 (64.9)
TRI+AID (%) 15 (51.7) 14 (48.3) 10 (76.9) 3 (23.1) 13 (35.1) 24 (64.9)
HRV (%) 16 (55.2) 13 (44.8) 5 (38.5) 8 (61.5) 3 (8.1) 34 (91.9)
Michigan (%) 2 (6.9) 27 (93.1) 0 (0) 13 (100) 0 (0.0) 37 (100)
EMG (%) 16 (55.2) 13 (44.8) 2 (15.4) 11 (84.6) 0 (0.0) 37(100)
TRI: thermal recovery index; IDA: interdigital anisothermal, HRV: heart
rate variability, (Michigan inventory); EMG: electromyography.
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with an abnormal plantar thermography result were older
than those who presented with a normal interdigital
thermographic pattern.
DISCUSSION
The presence of interdigital anisothermal using a simpli-
fied plantar thermographic study appears to be the most
appropriate diagnostic test for the early diagnosis of
neuropathy in the patients with DM and pre-DM. Because
of its sensitivity and specificity, in addition to its conve-
nience and timing, interdigital anisothermal assessed by
plantar thermography seems to be most suitable for diabetic
neuropathy screening programs. Its application is simple
using the proposed protocol, and it is cost-effective because
it requires no additional supplies.
It is important to identify diabetic neuropathy early to
prevent secondary complications, such as neuropathic pain
and diabetic foot (10,11,52,53). Unfortunately, because of
economic concerns and the lack of technological resources, a
consensus of international associations dedicated to treating
and preventing diabetes has advocated only using clinical
examination as a population screening method (56-59). In
this study, the clinical application of a validated clinical
inventory (Michigan inventory) did not identified neuro-
pathy even in cases with positive EMG, which would
certainly include late cases of neuropathy. Plantar thermo-
graphy is a new, non-invasive method that can be included
in neuropathy screening programs, thereby increasing the
sensitivity for proper diagnosis.
The current method for the early diagnosis of diabetic
neuropathy is a battery of tests, including methods capable
of assessing thick and thin nerve fibers, particularly the
autonomic nerve fibers (5,12). The two types of thermo-
graphic tests (thermal recovery index after the cold stress
test and the interdigital anisothermal test) demonstrated
differences in patterns between the three groups. These
patterns reflect the sympathetic nerve fibers with vasomotor
tone function and its effect on the skin temperature of the
feet (15,17,18).
Another benefit provided by plantar thermography for
chronic patients, such as those with DM, is the possibility of
following the evolutionary aspects of the disease because
thermography allows for functional imaging (60). Because
of the strict control of risk factors, such as glycemic control,
cutaneous vasomotor functionality of the feet can be
monitored periodically using this method.
In this study, plantar thermography proved useful in the
early diagnosis of diabetic neuropathy, particularly the
small and autonomic fibers that are commonly associated
with a sub-clinical condition. Future research studying the
thermal recovery index for diabetes duration would be
useful, particularly when comparing the density of nerve
fibers using skin biopsy and Quantitative Sensitive Test
(QST) to demonstrate a low sensitivity to heat. In addition, it
would be interesting to compare the potential amplitude of
the sural nerve, when present, with the thermographics
variable studied here (interdigital anisothermal and thermal
recovery index), as demonstrated by Shun et al. (61).
One limitation of this study is that it is a cross-sectional
study that involves a sensitive test. Therefore, follow-up will
be needed to assess the development of more advanced
forms of neuropathy and diabetic complications.
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